Reduced Burden of Oncologic Therapy in Advanced B-cell Lymphoma (REBOOT ABLY) in Children, Adolescents and Young Adults With CD20+ Mature B-Cell Lymphoma
Latest Information Update: 09 Nov 2021
At a glance
- Drugs Cytarabine (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Folinic acid; Methotrexate; Prednisone; Rituximab; Vincristine
- Indications B-cell lymphoma; Burkitt's lymphoma; Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms REBOOT; REBOOT ABLY
- 08 Dec 2020 Status changed from recruiting to completed, according to results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology.
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology
- 11 Mar 2019 Planned End Date changed from 1 Dec 2019 to 1 Jun 2019.